Pre-made Rafivirumab benchmark antibody ( Whole mAb, anti-RV Antigenic Site III therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Rafivirumab biosimilar, Whole Mab: Anti-RV Antigenic Site III therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Rafivirumab is a monoclonal antibody for the prophylaxis of rabies.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-465-1mg	1mg	3090
GMP-Bios-ab-465-10mg	10mg	Inquiry
GMP-Bios-ab-465-100mg	100mg	Inquiry
GMP-Bios-ab-465-xmg	＞100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Rafivirumab biosimilar, Whole Mab: Anti-RV Antigenic Site III therapeutic antibody
INN Name	Rafivirumab
Target	RV Antigenic Site III
Format	Whole mAb
Derivation	Human
Species Reactivity	Human
CH1 Isotype	IgG1
VD LC	Lambda
Highest_Clin_Trial (Jan '20)	Phase-II
Est. Status	Discontinued
100% SI Structure	None
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2008
Year Recommended	2009
Companies	Crucell;Sanofi Pasteur
Conditions Approved	na
Conditions Active	na
Conditions Discontinued	Rabies
Development Tech	Human Phage Display